Hotchkis & Wiley Capital Management
EBS icon

Hotchkis & Wiley Capital Management’s Emergent Biosolutions EBS Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,647,243
Closed -$3.95M – 498
2023
Q4 		$3.95M Sell
1,647,243
-781,247
-32% -$1.84M 0.01% 408
2023
Q3 		$8.26M Buy
2,428,490
+1,294,070
+114% +$7.17M 0.03% 245
2023
Q2 		$8.34M Buy
1,134,420
+190,760
+20% +$1.77M 0.03% 236
2023
Q1 		$9.78M Buy
943,660
+106,300
+13% +$1.28M 0.04% 177
2022
Q4 		$9.89M Buy
837,360
+484,860
+138% +$7.5M 0.04% 158
2022
Q3 		$7.4M Buy
352,500
+80,440
+30% +$2.24M 0.03% 206
2022
Q2 		$8.45M Buy
272,060
+28,800
+12% +$983K 0.03% 200
2022
Q1 		$9.99M Buy
243,260
+13,030
+6% +$575K 0.03% 182
2021
Q4 		$10M Buy
230,230
+79,000
+52% +$3.57M 0.03% 152
2021
Q3 		$7.57M Buy
+151,230
New +$9.16M 0.02% 223
2019
Q1 		– Sell
-35,794
Closed -$2.12M – 491
2018
Q4 		$2.12M Sell
35,794
-11,754
-25% -$758K 0.01% 314
2018
Q3 		$3.13M Buy
47,548
+12,356
+35% +$721K 0.01% 308
2018
Q2 		$1.78M Buy
35,192
+15,685
+80% +$817K 0.01% 344
2018
Q1 		$1.03M Hold
19,507
– – ﹤0.01% 317
2017
Q4 		$906K Buy
+19,507
New +$821K ﹤0.01% 324

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Hotchkis & Wiley Capital Management's EBS Position: Q1 2024 in Review

Hotchkis & Wiley Capital Management sold out of Emergent Biosolutions (EBS) in Q1 2024, closing a stake of 1,647,243 shares — an estimated $3.95M sold.

Hotchkis & Wiley Capital Management first reported a position in EBS in Q4 2017 and held it in 15 quarters. The position peaked at $10M in Q4 2021. 122 funds tracked by Wall St. Rank hold EBS as of Q1 2024.

  • Hotchkis & Wiley Capital Management reported no remaining Emergent Biosolutions position as of Q1 2024 after selling out during the quarter.
  • Hotchkis & Wiley Capital Management sold 1,647,243 Emergent Biosolutions shares in Q1 2024, an estimated $3.95M.
  • Hotchkis & Wiley Capital Management first reported a position in Emergent Biosolutions in Q4 2017 and held it in 15 quarters.
  • Hotchkis & Wiley Capital Management's Emergent Biosolutions position peaked at $10M in Q4 2021.
  • 122 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2024.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q1 2024, filed 14 May 2024.